Sponsored Links
Herpes Virus Cure
Goodbye Herpes Virus. Herpaflor® is 97.4% Effective; 100% Guaranteed!
Silver Antimicrobials
Superior product protection. Easy to adopt, FDA & EPA-approved.
First cases of spread of oseltamivir resistant swine flu between patients are reported in Wales
Press Release | www.bmj.com | 10 hours 27 minutes ago
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
http://www.bmj.com/cgi/content/short/339/nov23_2/b4975?rss=1
Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C (PR Newswire)
Press Release | finance.yahoo.com | 15 hours 17 minutes ago
PRINCETON, N.J., Nov. 23 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS - News) announced today that the enrollment of Cohort 2, led by its partner Roche (SWX:
http://finance.yahoo.com/news/Pharmasset-Announces-the-prnews-1401041265.html?x=0&.v=1
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
Press Release | www.prnewswire.com | Nov 2, 2009
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C. Interim results of Phase IIa NEXT-I study presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting.
BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
Press Release | www.pharmiweb.com | Nov 2, 2009
Study Addresses Unmet Medical Need for Difficult-to-Treat Patient Population BOSTON(BUSINESS WIRE)Bristol-Myers Squibb (NYSE: BMY) today announced 48-week data from an ongoing study (ETV-048) of chronic hepatitis B patients with decompensated cirrh
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9772
Triple-Combo Drug Shows Promise Against Antiviral-Resistant Swine Flu
Press Release | www.infectioncontroltoday.com | Oct 27, 2009
An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases.
http://www.infectioncontroltoday.com/hotnews/antiviral-resistant-swine-flu-drug-combo.html
Sponsored Links
STD Clinic in Los Angeles
See real doctor for STD concern $20 walk in consultation fee only
Natural Virus Prevention
Prevent the Flu - Homeopathic Alternative to the Flu Vaccine.
FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet
Press Release | www.pharmamanufacturing.com | Oct 23, 2009
The FDA is warning consumers to use extreme care when purchasing any products over the Internet that claim to diagnose, prevent, treat or cure the H1N1 influenza virus. The warning comes after the FDA recently purchased and analyzed several products represented online as Tamiflu (oseltamivir),
http://www.pharmamanufacturing.com/industrynews/2009/183.html?CMP=ILC-rss
Medical News: FDA Warns Pandemic Products on Web Could Be Phony - in Infectious Disease, Flu & URI
Press Release | www.medpagetoday.com | Oct 15, 2009
The FDA is warning against products sold over the Internet that claim to diagnose, prevent, treat, or cure the H1N1 flu.
http://www.medpagetoday.com/InfectiousDisease/URItheFlu/16459
FLAVORx Helps Families Fight Pandemic H1N1 Influenza Virus By Making Antiviral Medicine Taste Better
Press Release | www.prweb.com | Sep 17, 2009
PR: With the popular FLAVORx flavoring system for liquid medications, pharmacists are prepared to help children successfully take antiviral medications to fight the H1N1 and seasonal flu viruses. By improving the taste of these medications, including Tamiflu®, children are more likely to take their
Abbott Receives European Approval for Once-Daily Dosing of Kaletra® (lopinavir/ritonavir) Tablet
Press Release | www.abbott.com | Sep 14, 2009
Abbott Receives European Approval for Once-Daily Dosing of Kaletra® (lopinavir/ritonavir) Tablet
http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0768.htm?referrer=RSS
Two New Studies Report Increased Survival Rates in Tamiflu(R)-Treated Patients with Avian Flu (H5N1) and Severe Seasonal Flu
Press Release | news.prnewswire.com | Sep 13, 2009
SAN FRANCISCO, Sept. 13 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that two new observational studies concluded that influenza patients treated with Tamiflu(R) (oseltamivir phosphate) had significantly higher survival rates than untreated patients.
http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-13-2009/0005092764&EDATE=
Sponsored Links
Questions on Herpes Virus
Find Instant Answers to All Your Herpes Virus Questions on Bing ™.
